Elizabeth Read, MD
Obstetrics & Gynecology · Holland, OHNPI 1114921442
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $566 and has fallen 78.4% since, to $122 in 2025.
Across 103 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$338
- Astellas Pharma US Inc$319
- Exeltis, USA Inc.$167
- Pfizer$151
- Novo Nordisk$90
- Bayer$87
- plus $724 from 25 others
What the payments were for
- Food & beverage$1,77795%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $338 |
| Astellas Pharma US Inc | 9 | $319 |
| Exeltis, USA Inc. | 9 | $167 |
| Pfizer | 9 | $151 |
| Novo Nordisk | 5 | $90 |
| Bayer | 4 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $69 |
| CSL Behring | 3 | $66 |
| Mayne Pharma Commercial LLC | 3 | $62 |
| Sanofi | 3 | $53 |
| HEMA Biologics, LLC | 2 | $42 |
| Hologic Sales And Service, LLC | 3 | $41 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Grifols USA, LLC | 2 | $32 |
| AMAG Pharmaceuticals, Inc. | 2 | $29 |
| Genentech USA, Inc. | 1 | $26 |
| Myovant Sciences Inc. | 2 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Sage Therapeutics, LLC | 1 | $23 |
| Organon | 1 | $22 |
| Vertex | 1 | $18 |
| Biomarin Pharmaceutical Inc. | 1 | $18 |
| Amgen | 1 | $15 |
| Minerva Surgical, Inc | 1 | $15 |
| Genentech, Inc. | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $12 |
| Tactile Systems Technology Inc | 1 | $11 |
| Lupin Inc. | 1 | $11 |
| Merck | 1 | $11 |
| Coopersurgical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$125
How this compares
$1,876 in reported general payments places this provider in the 75th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 33 | $1,812 |
| Risedronate Sodium | 15 | $947 |
| Clobetasol Propionate | 16 | $269 |
| Medroxyprogesterone Acetate | 11 | $190 |
| Triamcinolone Acetonide | 40 | $161 |
| Alendronate Sodium | 12 | $141 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Holland
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
- Sandor MecsSteubenville$190K
- David SchwartzCincinnati$169K
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Lorie Thomas-SchultzFindlay$92K
- Oluwatosin GojeCleveland$81K
- Gerard ReillyCincinnati$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.